Chemours, a chemical giant, disclosed that an internal investigation uncovered unethical financial practices by three executives to inflate their incentive compensation. The investigation revealed cash flow manipulation to meet annual targets for stock and bonus awards, leading to scrutiny and concerns over accounting integrity.
Chemical giant Chemours announced that an internal investigation revealed that three executives engaged in unethical financial practices to boost their incentive compensation. https://t.co/WnVopjan49
Who's been cooking the books over at $CC??? https://t.co/hSIeX5a8Cl
Shady shenanigans at Chemours $CC C-Suite Execs' accounting was curlier than a villain's 'stache. Good thing the #UOA caught it. @jonnajarian @petenajarian Rebel's Edge 🏴☠️ 1pm #CC #stockmarket #busted #itsnotanoption https://t.co/FIrRKXzryM